MedTrace Logo

Utilizing a Novel Method to Map Sources of Atrial Fibrillation

NCT02523534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-11-07

No results posted yet for this study

Summary

This is an electrogram mapping study that tests the ability of a new signal processing technique called electrogram morphology recurrence mapping to locate drivers in participants with atrial fibrillation. This study will also test the hypothesis that there are non-invasive markers that can predict driver location. Electrogram mapping will be performed in participants undergoing ablation for persistent atrial fibrillation. These participants will have a cardiac MRI and 12-lead ECG prior to the ablation procedure.

Conditions

Interventions

PROCEDURE

MRI

MRI images will be taken in conjunction with the clinically indicated cardiac MRI.

PROCEDURE

ECG

ECG readings will be taken prior to the participants clinically indicated procedure.

Sponsors & Collaborators

Principal Investigators

  • Jason Ng, PhD · Northwestern University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2020-08-31
Completion
2021-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523534 on ClinicalTrials.gov